trapped gas semaglutide Semaglutide- for weight loss in obesity How to Manage (or Prevent)

"This is particularly concerning given that people with obesity-related comorbidities may reap the greatest benefit from treatment," Thomsen said

BPC-157 fixes damaged tissues

But 55% of microdosers are doing this without medical oversight, and many are using compounded formulations with variable quality

N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

This reduction was driven by reductions in both bolus (6.2 U [14.1, 3.5]) and basal insulin (3.5 U [9.7, 0.3])